- Home
- ARQT vs GSHD Comparison
ARQT vs GSHD Comparison
Compare ARQT & GSHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- GSHD
- Stock Information
- Founded
- ARQT 2016
- GSHD 2003
- Country
- ARQT United States
- GSHD United States
- Employees
- ARQT N/A
- GSHD N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- GSHD Specialty Insurers
- Sector
- ARQT Health Care
- GSHD Finance
- Exchange
- ARQT Nasdaq
- GSHD Nasdaq
- Market Cap
- ARQT 2.1B
- GSHD 2.2B
- IPO Year
- ARQT 2020
- GSHD 2018
- Fundamental
- Price
- ARQT $17.71
- GSHD $80.36
- Analyst Decision
- ARQT Strong Buy
- GSHD Hold
- Analyst Count
- ARQT 7
- GSHD 10
- Target Price
- ARQT $19.00
- GSHD $107.80
- AVG Volume (30 Days)
- ARQT 1.6M
- GSHD 257.3K
- Earning Date
- ARQT 11-05-2025
- GSHD 10-22-2025
- Dividend Yield
- ARQT N/A
- GSHD 7.30%
- EPS Growth
- ARQT N/A
- GSHD 81.48
- EPS
- ARQT N/A
- GSHD 1.14
- Revenue
- ARQT $263,464,999.00
- GSHD $340,762,000.00
- Revenue This Year
- ARQT $72.46
- GSHD $17.71
- Revenue Next Year
- ARQT $31.69
- GSHD $23.41
- P/E Ratio
- ARQT N/A
- GSHD $70.84
- Revenue Growth
- ARQT 99.50
- GSHD 23.70
- 52 Week Low
- ARQT $8.03
- GSHD $77.74
- 52 Week High
- ARQT $18.15
- GSHD $130.39
- Technical
- Relative Strength Index (RSI)
- ARQT 63.97
- GSHD 38.67
- Support Level
- ARQT $16.62
- GSHD $77.74
- Resistance Level
- ARQT $18.15
- GSHD $84.36
- Average True Range (ATR)
- ARQT 0.69
- GSHD 2.58
- MACD
- ARQT 0.03
- GSHD 0.05
- Stochastic Oscillator
- ARQT 85.57
- GSHD 27.58
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions.